2017
DOI: 10.1016/j.phrs.2017.05.018
|View full text |Cite
|
Sign up to set email alerts
|

Propranolol treatment lowers blood pressure, reduces vascular inflammatory markers and improves endothelial function in obese mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
6
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 17 publications
(8 citation statements)
references
References 58 publications
1
6
1
Order By: Relevance
“…However, other cardiometabolic parameters such as plasma insulin and glucose as well as systolic arterial blood pressure were not significantly elevated in either of the HFD groups compared to groups fed the normal diet. This is in contrast with a previous study in mice on a 54% kcal fat diet for only 8 weeks (da Silva Franco et al, 2017 ). In terms of plasma glucose and insulin, most studies report a rise induced by HFD, even after only 4 weeks of feeding (Guilford et al, 2017 ), but others have found no change after 6 weeks (60% kcal of fat diet; Zhang et al, 2017 ).…”
Section: Discussioncontrasting
confidence: 93%
“…However, other cardiometabolic parameters such as plasma insulin and glucose as well as systolic arterial blood pressure were not significantly elevated in either of the HFD groups compared to groups fed the normal diet. This is in contrast with a previous study in mice on a 54% kcal fat diet for only 8 weeks (da Silva Franco et al, 2017 ). In terms of plasma glucose and insulin, most studies report a rise induced by HFD, even after only 4 weeks of feeding (Guilford et al, 2017 ), but others have found no change after 6 weeks (60% kcal of fat diet; Zhang et al, 2017 ).…”
Section: Discussioncontrasting
confidence: 93%
“…We found no differences in ROS generation, total eNOS expression, or the degree of eNOS serine 1177 phosphorylation, an important posttranslational modification that enhances eNOS activity. Although increased vascular ROS generation has be found in response to obesity, dyslipidemia, and metabolic syndrome,46 in early stages of obesity, vascular oxidative stress might not be present 47, 48. We cannot exclude the possibility that risk factors modify eNOS activity and NO bioavailability through modulation of a different eNOS phosphorylation site other than serine 1177, such as the inhibitory threonine 495 phosphorylation site or others.…”
Section: Discussionmentioning
confidence: 94%
“…Although increased vascular ROS generation has be found in response to obesity, dyslipidemia, and metabolic syndrome, 46 in early stages of obesity, vascular oxidative stress might not be present. 47,48 We cannot exclude the possibility that risk factors modify eNOS activity and NO bioavailability through modulation of a different eNOS phosphorylation site other than serine 1177, such as the inhibitory threonine 495 phosphorylation site or others. In obese males only, the impairment in NO was associated with increased EDHmediated relaxation and a specific increase in mesenteric protein expression of the endothelial SK3 potassium channel.…”
Section: Controlmentioning
confidence: 99%
“…Insulin enhances the expression and activity of eNOS in endothelial cells by upregulating the PI3K/Akt pathway, which induced endothelium-dependent relaxation (Montagnani et al, 2002 ; Potenza et al, 2009 ). However, hyperinsulinemia and insulin resistance favor the insulin-dependent activation of MAP-kinases (MAPK), which is associated with the elevated expression of proinflammatory and atherogenic factors (Eringa et al, 2004 ; Cersosimo et al, 2012 ; da Silva Franco et al, 2017 ). The presence of PVAT prevented the reduced insulin-induced relaxation in aorta of LDLr-KO mice.…”
Section: Discussionmentioning
confidence: 99%